Multiagent chemotherapy for children with metastatic neuroblastoma: a report from Childrens Cancer Study Group. 1979

J Z Finklestein, and M R Klemperer, and A Evans, and I Bernstein, and S Leikin, and S McCreadie, and J Grosfeld, and R Hittle, and J Weiner, and H Sather, and D Hammond

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D007223 Infant A child between 1 and 23 months of age. Infants
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D009447 Neuroblastoma A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51) Neuroblastomas
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J Z Finklestein, and M R Klemperer, and A Evans, and I Bernstein, and S Leikin, and S McCreadie, and J Grosfeld, and R Hittle, and J Weiner, and H Sather, and D Hammond
January 1992, Medical and pediatric oncology,
J Z Finklestein, and M R Klemperer, and A Evans, and I Bernstein, and S Leikin, and S McCreadie, and J Grosfeld, and R Hittle, and J Weiner, and H Sather, and D Hammond
October 1988, Human pathology,
J Z Finklestein, and M R Klemperer, and A Evans, and I Bernstein, and S Leikin, and S McCreadie, and J Grosfeld, and R Hittle, and J Weiner, and H Sather, and D Hammond
January 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
J Z Finklestein, and M R Klemperer, and A Evans, and I Bernstein, and S Leikin, and S McCreadie, and J Grosfeld, and R Hittle, and J Weiner, and H Sather, and D Hammond
December 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
J Z Finklestein, and M R Klemperer, and A Evans, and I Bernstein, and S Leikin, and S McCreadie, and J Grosfeld, and R Hittle, and J Weiner, and H Sather, and D Hammond
April 1989, Cancer,
J Z Finklestein, and M R Klemperer, and A Evans, and I Bernstein, and S Leikin, and S McCreadie, and J Grosfeld, and R Hittle, and J Weiner, and H Sather, and D Hammond
April 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
J Z Finklestein, and M R Klemperer, and A Evans, and I Bernstein, and S Leikin, and S McCreadie, and J Grosfeld, and R Hittle, and J Weiner, and H Sather, and D Hammond
November 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
J Z Finklestein, and M R Klemperer, and A Evans, and I Bernstein, and S Leikin, and S McCreadie, and J Grosfeld, and R Hittle, and J Weiner, and H Sather, and D Hammond
January 1980, Medical and pediatric oncology,
J Z Finklestein, and M R Klemperer, and A Evans, and I Bernstein, and S Leikin, and S McCreadie, and J Grosfeld, and R Hittle, and J Weiner, and H Sather, and D Hammond
October 1984, American journal of clinical oncology,
J Z Finklestein, and M R Klemperer, and A Evans, and I Bernstein, and S Leikin, and S McCreadie, and J Grosfeld, and R Hittle, and J Weiner, and H Sather, and D Hammond
August 1983, Lancet (London, England),
Copied contents to your clipboard!